Melissa Sue Evans, APN-C Nurse Practitioner - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 125 Chubb Ave, Lyndhurst, NJ 07071 Phone: 201-559-7600 |
Christine Castelluber, APN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 477 Stuyvesant Ave, Lyndhurst, NJ 07071 Phone: 201-933-2333 |
Ms. Mary M Restaino, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 419 6th Ave, Lyndhurst, NJ 07071 Phone: 201-951-4226 |
Justin Sion Salandanan, APN Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 516 Valley Brook Ave, Lyndhurst, NJ 07071 Phone: 201-935-3322 |
News Archive
Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has filed with the U.S. Food and Drug Administration for clearance of the company's Vas Zeppelin Smart Catheter for the treatment of chronic pulmonary diseases and lung cancer.
LiveData and KARL STORZ Endoscopy- America, Inc. today announced that East Cooper Medical Center will install the companies' Patient-Aware OR solution in the eight operating rooms in East Cooper's new hospital to be opened this quarter. KARL STORZ is a global leader in minimally invasive endoscopic technologies and operating room integration. LiveData is a leader in real-time data integration and display technology.
News outlets analyze the political pressure and partisan in-fighting that is taking shape as the sequester countdown continues. Meanwhile, McClatchy and The New York Times attempt to answer questions about the impact of the scheduled cuts.
Owing to the generosity of Quebecers, 499 organs from 138 deceased donors in 2009 were transplanted into 431 recipients. Though there were 13 fewer donors than in 2008, Québec posted an average of more than 3.6 transplanted organs per deceased donor in 2009, placing the province among the leaders in Canada and even North America. "We're particularly proud of the sustained collaboration of professionals in hospitals in 2009," says Louis Beaulieu, chief executive officer of Québec-Transplant, the organization responsible for coordinating the organ donation process.
SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases, today announced that it has successfully completed a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for its lead compound SM101, which is being developed for the treatment of Primary Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE).
› Verified 8 days ago